Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Jaffe

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Archives of Neurology|April 13, 2011
Translational neurologyRobert Jaffe
Physical Review Letters|December 20, 2003
Diquarks and exotic spectroscopyRobert Jaffe, Frank Wilczek
Journal of American College Health : J of ACH|August 23, 2007
A qualitative study of attitudes, beliefs, and practices among 40 undergraduate smokersBeti Thompson, L Anne Thompson, Jennifer Hymer, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 17, 2007
Prevalence and characteristics of smokers at 30 Pacific Northwest colleges and universitiesBeti Thompson, Gloria Coronado, Lu Chen, et al.
Seminars in Oncology|November 13, 2003
Linking molecular diagnostics to molecular therapeutics: targeting the PI3K pathway in breast cancerGordon B Mills, Elise Kohn, Yiling Lu, et al.
Biochimica Et Biophysica Acta|June 19, 2002
Lysophosphatidic acid is a bioactive mediator in ovarian cancerXianjun Fang, Michel Schummer, Muling Mao, et al.
Gynecologic Oncology|February 15, 2003
Specific keynote: molecular therapeutics in ovarian cancerGordon B Mills, Xianjun Fang, Yiling Lu, et al.
The Lancet. Oncology|October 14, 2011
Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancerRobert L Coleman, Linda R Duska, Pedro T Ramirez, et al.
Cancer Treatment and Research|January 5, 2002
Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancerGordon B Mills, Astrid Eder, Xianjun Fang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Archives of Neurology|April 13, 2011
Translational neurologyRobert Jaffe
Physical Review Letters|December 20, 2003
Diquarks and exotic spectroscopyRobert Jaffe, Frank Wilczek
Journal of American College Health : J of ACH|August 23, 2007
A qualitative study of attitudes, beliefs, and practices among 40 undergraduate smokersBeti Thompson, L Anne Thompson, Jennifer Hymer, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 17, 2007
Prevalence and characteristics of smokers at 30 Pacific Northwest colleges and universitiesBeti Thompson, Gloria Coronado, Lu Chen, et al.
Seminars in Oncology|November 13, 2003
Linking molecular diagnostics to molecular therapeutics: targeting the PI3K pathway in breast cancerGordon B Mills, Elise Kohn, Yiling Lu, et al.
Biochimica Et Biophysica Acta|June 19, 2002
Lysophosphatidic acid is a bioactive mediator in ovarian cancerXianjun Fang, Michel Schummer, Muling Mao, et al.
Gynecologic Oncology|February 15, 2003
Specific keynote: molecular therapeutics in ovarian cancerGordon B Mills, Xianjun Fang, Yiling Lu, et al.
The Lancet. Oncology|October 14, 2011
Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancerRobert L Coleman, Linda R Duska, Pedro T Ramirez, et al.
Cancer Treatment and Research|January 5, 2002
Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancerGordon B Mills, Astrid Eder, Xianjun Fang, et al.
Pageof 1